TNFRSF1B and colitis: However, a study demonstrates recently that the transfer of colitogenic CD4+CD45hiTNF-R2−/− T cells into RAG−/− recipients leads to acceleration of the onset of overt disease and to aggravated severity of intestinal inflammation [9], indicating an opposite effect of TNF-R2 expression by CD4+ T cells on the course of colitis.